NCT02447536View on ClinicalTrials.gov

Trial of Two Strains of BCG

PHASE4CompletedINTERVENTIONAL
Enrollment

12,006

Participants

Timeline

Start Date

December 8, 2014

Primary Completion Date

November 24, 2017

Study Completion Date

May 1, 2018

Conditions
MorbidityBacille Calmette-Guérin
Interventions
BIOLOGICAL

BCG-Denmark 1331 (Statens Serum Institute)

See above

BIOLOGICAL

BCG-Russia-I (Serum Institute of India)

See above

Trial Locations (1)

Unknown

Bandim Health Project, Apartado 861, Bissau

All Listed Sponsors
collaborator

Statens Serum Institut

OTHER

lead

Bandim Health Project

OTHER

NCT02447536 - Trial of Two Strains of BCG | Biotech Hunter | Biotech Hunter